Magazine Article | August 2, 2018

Fibrocell: Where Gene Therapy Meets Synthetic Biology

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

The Enterprisers: Life Science Leadership In Action

Biotechnology once meant only one thing — manufacturing human proteins by means of recombinant DNA applied to microorganisms, usually in fermentation. Now we speak of the life sciences, enlarging the world of biotech to encompass new technologies such as gene therapy and regenerative medicine. In The Enterprisers, as in the monthly Companies to Watch, I am now exploring that new ground, really a new geography of therapeutic areas joining and even cross-bordering with the pharmaceutical and biological therapeutics that always have been my beat. Fibrocell is developing therapeutics for rare skin disorders, using a new approach for gene therapy as a regenerative-medicine tool.